DoctorJac Charlesworth

Adjunct Senior Researcher

Menzies Institute for Medical Research

  • Adjunct Senior Researcher
    Menzies Institute for Medical Research
  • +61 3 6226 4607 (Work)
  • University of Tasmania, IT Services, Corporate Services Building, TT Flynn St, Sandy Bay, TAS, 7005, Australia

RESEARCH SUMMARy

Expertise

Computational genomics
Complex disease genetics
Multiple sclerosis
Neurodegeneration
Neurogenetics
Bioinformatics
Ophthalmic genetics
Extended pedigree studies
Next-generation sequencing analysis
Genomics
Transcriptomics
Network analysis
Glaucoma

Collaboration

Dr Charlesworth works in close collaboration with the South Texas Diabetes and Obesity Institute, at the University of Texas Rio Grande Valley in the USA. She is mentored by Professor John Blangero and has long running collaborations with many members of the institute. Their shared research interests include complex disease genetics and the use of extended pedigrees for gene identification, particularly for brain structure and function. Dr Charlesworth has been working with Professor Blangero and his team since 2004. She also collaborates closely with Dr Mary Wirtz from the Casey Eye Institute at the Oregon Health and Science University in the USA. Dr Wirtz and Dr Charlesworth have been working together on ophthalmic genetics since 2006.

Current projects

The Menzies MS family sequencing study

Genetics plays an important role in MS risk. ‘Case-control’ studies have helped us identify some of the population-level genetics risk factors for MS, but can’t provide the kind of genetic information that leads to new treatments. Families with multiple cases of MS are uncommon, but they do exist. Those families allow us to use ‘precision’ or personalised medicine approaches to pinpoint specific genetic differences that might lead to MS development.

This project studies the genomes of families with MS to determine why some people are more susceptible to nerve damage following the immune attack. In this study we work with families who have several people with MS, and sequence the genomes of everyone (with or without MS) to determine if there are genetic differences that explain why some people develop MS. This work will find new MS risk genes and lead to treatments aimed at protecting or repairing the nervous system.

The genetics of brain lesion formation

MRI scans of the brain show that most people have some small degree of demyelination and neurorepair, and that these processes are partly controlled by genetics. Understanding more about the biology and genetics of ‘normal’ variation in brain lesion formation and repair will also help us understand how these pathways might be disturbed in diseases such as MS.

This study is run in collaboration with Yale University and the University of Texas Rio Grande Valley and uses brain imaging and genomic data from hundreds of people in large families without any major neurological disease. We are using these data to find genes involved in the normal biological processes of lesion formation and repair, so that we can then study them in diseases where these processes go awry, such as MS.

FUNDED PROJECTS

  • CONSULTANCY/CONTRACT RESEARCH
    University of Tasmania Nectar Node 2025-2026
    1 Jan 2025 - 30 Jun 2026
    People funded by this grant:
    • Charlesworth J,
    • Taylor M,
    • Armsby M
    Project Total: $418,831; This project will operate of the University of Tasmania (UTAS) Node of the Nectar Research Cloud through to 30 June 2026. UTAS operates national research infrastructure funded by previous ARDC contracts within the Nectar Research Cloud.The project aims to extend UTASs role in operating this Node and the associated ARDC-funded infrastructure, ensuring sustained support for national research infrastructure. The Node must adhere to the standards, policies and procedures of the Nectar Research Cloud federation including those specified in the Nectar Operational Level Agreement (OLA). ARDCs Nectar Cloud Services team will continue to support UTAS in managing the University of Tasmania Nectar Node. Funded by: Australian Research Data Commons ($418,831); University of Tasmania ($550,594).
  • GRANT
    Node GPU and large memory servers for the ARDC Nectar Research Cloud
    18 Feb 2022 - 18 Feb 2025
    People funded by this grant:
    • Charlesworth J,
    • Armsby M,
    • Goetz K
    Project Total: $195,000; The project will deploy GPU and/or large memory servers in the Nectar Research Cloud in order to increase the capacity of specialised and high-end cloud infrastructure for nationally prioritised project allocations. This new infrastructure is to be operated as a resource for national allocation for 3 years after it is commissioned. The GPU and large memory servers will be available to projects with national merit allocations and accessed through a national reservation system. As with existing ARDC-funded infrastructure in the Nectar cloud, the new infrastructure will be prioritised for use by national project allocations that are associated with the Node hosting the servers. Funded by: Australian Research Data Commons - Delivery of eResearch Infrastructure: Nectar ($195,000); University of Tasmania ($187,000).
  • GRANT
    Does a familial gene variant drive neurodegeneration in Multiple Sclerosis?
    1 Jan 2022 - 31 Dec 2022
    People funded by this grant:
    • Fletcher J,
    • Young K,
    • Charlesworth J
    Project Total: $33,000; We have identified a variant of the NLRX1 gene in a family with an unusually high incidence of MS. This project will characterise the cellular and molecular consequences of this NLRX1 variant in vitro using human induced pluripotent stem cell lines (iPSC) generated from the family members with MS to determine if it is involved in generating the neurodegeneration and neurologic disability experienced by people with MS. The expected outcome of this project is new insight into how neurodegeneration in MS is initiated, the identification of new therapeutic strategies and the first ever in vitro genetic models of MS. Funded by: Brain Foundation - Grant-Research ($33,000); University of Tasmania.
  • GRANT
    ARDC Data Retention Project Phase 1: Existing Collections
    14 Dec 2020 - 30 Jun 2023
    People funded by this grant:
    • Charlesworth J,
    • Dillon A,
    • Davey B
    Project Total: $483,000; Ongoing data management, tech support. The Data Retention project is a three year 'stakeholder partnership' designed to increase the impact of investment in underpinning infrastructure for national data collections. Partnerships in the Data Retention project will leverage current research data management practices to enrich data collections with controlled and consistent metadata to drive the FAIR data principles. Funded by: Australian Research Data Commons - Data Retention Project ($483,000); University of Tasmania.
  • GRANT
    Refreshing the TPAC NeCTAR Cloud Node
    18 Mar 2020 - 30 Jun 2023
    People funded by this grant:
    • Charlesworth J,
    • Tenaglia N,
    • Armsby M,
    • Berkhout J,
    • Fu XM
    Project Total: $1,287,028; This Proposal is for the refresh of the existing NeCTAR node operated by the University of Tasmania through the Tasmanian Partnership for Advanced Computing (TPAC). The refresh will uplift performance of the node, bring new capabilities to this cloud and sustain the long term reliability of the service. It consolidates the position of the current node as the third largest in the Australian NeCTAR federation. A remarkable achievement built on the extraordinary research community in Tasmania. Funded by: Australian Research Data Commons - Delivery of eResearch Infrastructure: Nectar ($1,287,028); University of Tasmania ($250,000).
  • GRANT
    Identifying the Genetic Causes and Modifiers of Paediatric Cataract
    1 Jan 2020 - 31 Dec 2023
    People funded by this grant:
    • Burdon K,
    • Ruddle J,
    • McComish B,
    • Kearns L
    Project Total: $1,011,130; In children and infants, cataract, or opacity of the lens of the eye, is a severe and debilitating disease that can lead to lifelong visual impairment or blindness. Genetic testing is an important part of the diagnosis of inherited paediatric cataract, however, currently known genes account for less than 60% of patients with this heterogeneous disease. The variability in disease severity and penetrance also complicates the interpretation of genetic tests and genetic counselling. To improve the utility of genetic testing for the diagnosis and management of paediatric cataract we need to identify the remaining causative genes and understand how other factors including modifier genes affect the severity of disease. Our lab houses an extensive DNA repository of over 200 families with inherited paediatric cataract, including 61 families with no known gene mutations, and an additional collection of over 50 affected individuals. This is one of the largest collections of DNA from patients with this disease in the world. Using this valuable resource, we will discover new genes for paediatric cataract in our unsolved families through an innovative use of linkage analysis combined with whole genome sequencing. We will confirm the pathogenicity of newly discovered genes, including two novel genes we have recently identified in Australian families, by gene knockout in a zebrafish model. We will extend these ideas further and undertake the first ever attempt to identify modifier genes for paediatric cataract. We are uniquely placed to do this as our repository contains several large families with highly variable disease severity amenable to gene mapping. The findings from this research will markedly improve the completeness of genetic tests for paediatric cataract and will begin to shed light on the complex nature of the disease in some families. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($2,022,260); University of Tasmania.
  • GRANT
    The Menzies Multiple Sclerosis Flagship Program
    1 Jan 2020 - 30 Jun 2024
    People funded by this grant:
    • Taylor B,
    • Young K,
    • Charlesworth J,
    • van der Mei I,
    • Palmer A
    Project Total: $10,000,000; The Menzies Institute for Medical Research Multiple Sclerosis Flagship Program (MS Flagship) leverages the unique critical mass of MS research in Tasmania connected with Australian MS researchers, collaborators, MS societies and people with MS to address the gaps in the assessment, diagnosis and treatment of MS. Our work builds on our well-developed collaborations and laboratory, epidemiological, health economics and clinical research platforms. Our aim is to improve the clinical management of MS by slowing, halting and even reversing the rate of MS disease progression and to improve the quality of life and reduce the impact that MS has on individuals, their families and society. This project will expand the scope of the MS Flagship program and accelerate discoveries in MS research by supporting five key Activities: 1. Establish 'MS Stem' - a stem cell bank specifically designed to advance MS research 2. Gain a better understanding of the regeneration of brain cells and myelin repair 3. Expand our understanding of the rare genetic variation underpinning MS using genome sequencing of MS families and 'MS Stem' cell bank samples 4. Develop a treatment economic model which can identify cost-effective treatments and interventions for MS 5. Develop education tools and online resources, including an App specifically for people living with MS Funded by: Medical Research Future Fund - Grant - Accelerated Research ($10,000,000); University of Tasmania.
  • GRANT
    The modulation of multiple sclerosis (MS) relapse risk by genetic variations in the LRP2 gene
    1 Feb 2018 - 31 Jan 2019
    People funded by this grant:
    • Zhou Y,
    • Taylor B,
    • Charlesworth J,
    • Burdon K
    Project Total: $24,933; This work will sequence the associated LRP2 gene region to identify the functional variants that modulate MS relapse risk, which is the primary endpoint of many pivotal clinical trials testing the efficacy of MS disease-modifying drugs. Funded by: Royal Hobart Hospital Research Foundation - Grant-Minor Project ($24,933); University of Tasmania.
  • GRANT
    A family-based approach to studying neurodegeneration in multiple sclerosis
    1 Jan 2018 - 31 Dec 2018
    People funded by this grant:
    • Charlesworth J,
    • Young K,
    • Burdon K,
    • Taylor B,
    • McComish B
    Project Total: $24,928; Multiple sclerosis (MS) is the most common, disabling nervous system disease in young adults. In MS, the immune system attacks the brain and spinal cord, and current treatments act to suppress the immune system not repair the damage. This project studies the genetics of families with MS to determine why some people are more susceptible to nerve damage following the immune attack. We use whole genome sequencing of all closely related individuals in families, including three of more people with MS, and study their genomes to find the genetic differences between affected and unaffected relatives. This work will find new MS risk genes that can be further studied by our laboratory-based stem cell biology team using cell-based models of disease. The research will ultimately lead to treatments aimed at protecting or repairing the nervous system. Funded by: University of Tasmania - Grant- Research Enhancement Program; University of Tasmania ($24,928).
  • GRANT
    Identifying pathological pathways and putative therapeutics for the treatment of nervous system pathology in people with Multiple Sclerosis
    1 Jan 2018 - 31 Dec 2021
    People funded by this grant:
    • Pitman K,
    • Young K,
    • Taylor B,
    • Charlesworth J,
    • Hewitt A
    Project Total: $448,999; DNA sequencing of Tasmanian families with multiple closely related MS cases has implicated the GRIK4 gene in the development of this disease. This project aims to understand how GRIK4 affects the central nervous system, determine its role in disease pathogenesis, and repurpose existing pharmaceuticals targeting this pathway to offset neurodegeneration. Funded by: Royal Hobart Hospital Research Foundation - Grant-Major Project ($448,999); University of Tasmania.
  • GRANT
    Investigating glutamate transporters in the brain?
    1 Jan 2018 - 31 Dec 2018
    People funded by this grant:
    • Beasley S,
    • Young K,
    • Dickson T,
    • Charlesworth J,
    • Taylor B
    Project Total: $10,186; Too much of a 'good thing' can be bad, especially when it comes to the brain. Glutamate is an important signalling molecule that allows nerves to talk to each other, but it can be toxic if too much is present. The brain has protective machinery in place to move glutamate into cells where it can be detoxified?, but if this transport machinery fails, the brain can be damaged. People with multiple sclerosis (MS) have abnormally high levels of glutamate outside of brain cells, both within brain lesions and in seemingly healthy parts of the brain. Dysfunction of the glutamate uptake machinery may be responsible, or at the very least contribute to higher glutamate levels and cause further damage in MS. However, we currently know very little about the levels of the glutamate uptake machinery in healthy people. The main aim of this project will be to examine glutamate uptake machinery in the brains of healthy people, in order to establish appropriate background data so that this information will be available for future studies in MS brain. In addition, I will undertake some studies in mouse brain, to determine if this would be an appropriate model for future MS studies. Funded by: University of Tasmania - Grant- Research Enhancement Program; University of Tasmania ($10,186).
  • GRANT
    Investigating the role of short tandem repeat sequence variation in multiple sclerosis.
    1 Jan 2018 - 31 Dec 2018
    People funded by this grant:
    • McComish B,
    • Charlesworth J,
    • Burdon K
    Project Total: $25,000; We will use data from extended families with a dense clustering of MS cases to identify rare short tandem repeat variants associated with multiple sclerosis. Highly ranked variants will be further investigated in MS and control cohorts to identify correlations between STR allele length and the severity and age of onset of MS. Funded by: Multiple Sclerosis Australia - Grant-Incubator ($25,000); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Identifying the Underlying Genetic Drivers of IPF using Complementary Approaches
    1 Jan 2017 - 31 Dec 2024
    People funded by this grant:
    • Dickinson J,
    • Corte T,
    • Holloway A,
    • Charlesworth J,
    • Walters H
    Project Total: $1,481,558; In the first instance the goal is to define the contribution of genetic variants to IPF in the Australian population, and we are in a unique position in Australia through our collaboration with Professor Schwartz. Our focus in this particular project is on rare genetic variation, and whilst it is likely that common variation will be similar to other mostly Caucasian populations there are likely to be differences in the rare variants in genes contributing to disease in the different populations. It is therefore important that these types of studies are performed in our population if we are going to understand the biology of disease in our patients. As discussed the identification of rare variants underpinning complex disease is proving fruitful both in understanding the biology of disease, the spectrum of clinical manifestations observed and importantly providing new potential targets for therapy. Funded by: Lung Foundation Australia ($1,481,558); University of Tasmania.
  • GRANT
    How do rare genetic variants cause multiple sclerosis?
    1 Apr 2016 - 31 Dec 2016
    People funded by this grant:
    • Charlesworth J,
    • Young K,
    • Pitman K
    Project Total: $35,000; To determine how rare genetic variants, identified by whole-genome sequencing multiple sclerosis (MS) families, influence cell function. Funded by: Menzies Institute for Medical Research - Grant - Development Grant; University of Tasmania ($35,000).
  • GRANT
    Gene Identification for Keratoconus - a Blinding Eye Disease
    1 Jan 2016 - 31 Dec 2019
    People funded by this grant:
    • Burdon K,
    • Charlesworth J,
    • Baird P,
    • Mills R,
    • Sharma S
    Project Total: $912,880; Keratoconus is a disease of the cornea at the front of the eye characterized by progressive corneal thinning and conical protrusion, leading to severe vision loss and potentially blindness. The causes are not understood and current treatments are invasive and suboptimal. Keratoconus has a major genetic component, most of which remains unexplained. We will identify novel genes and variants contributing to keratoconus risk with the aim of increasing understanding of the molecular causes of this disease. We will apply state-of-the art whole genome sequencing technology to a traditional family based gene discovery approach, incorporating linkage analysis to guide variant prioritization in large families with autosomal dominant keratoconus. Genes in which we identify candidate mutations will be re-sequenced in our unique Australian cohort of 672 keratoconus patients to identify additional variants contributing to disease in these genes. Genome-wide association studies for keratoconus and the endophenotype of central corneal thickness have recently identified four loci reaching robust statistical significance for association with keratoconus. We will dissect these loci to identify the likely causative variants through detailed fine mapping and re-sequencing of the risk haplotype in our cohort. Bioinformatics will be used to rank variants for their likely involvement and to prioritise them for future functional work. These experiments will be further complemented by our International collaborations allowing access to data from additional keratoconus cases in which high ranked variants will be assessed for association. We will also investigate the expression level of genes at each of the loci in diseased and normal cornea to determine if these are the genes influenced by the observed SNP associations. In summary, this project will identify novel genes and variants associated with keratoconus, furthering our understanding of the processes underlying this disease. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project ($1,825,760); University of Tasmania.
  • GRANT
    Tasmanian Genetic Research in Inherited Disease (TasGRID)
    1 Jan 2015 - 31 Dec 2017
    People funded by this grant:
    • Dickinson J,
    • Burdon K,
    • Charlesworth J,
    • Chalmers D,
    • Nicol D
    Project Total: $200,000; The aim of this project is to generate􀀿 'genomics hub' building on current research expertise, laboratory facilities, analytical capabilities, by providing a co-ordinated administration hub and core genomics reference resource. The Menzies has a strategic focus on utilising the unique features of the Tasmanian population for health research Including genomlcs to address the burden of disease in Tasmania. A/Prof Dickinson's team has attracted nationally competitive funding to build expertise, bioinformatics analysis skills in genomics, a laboratory facility equipped with next generation sequencing technology and a computing facility. The funding requested will address two immediate needs * a 'genomics hub' co-ordinator, and * a Tasmanian reference genome database. This will facilitate expansion of genomics research in Tasmania, by providing the necessary foundation for leveraging external funding, providing world-class training opportunities for students and importantly will position the University to keep pace internationally in the field of genomics. Funded by: University of Tasmania - Grant-Strategic Research; University of Tasmania ($632,000).
  • GRANT
    Familial Haematological Malignancies: understanding the role of inherited causative factors
    1 Mar 2014 - 30 Jun 2015
    People funded by this grant:
    • Dickinson J,
    • Charlesworth J,
    • Foote S,
    • Thomson R,
    • Holloway A
    Project Total: $20,000; Genetic factors are known to contribute to the risk of developing haematological malignancies, however to date the underlying genetic drivers of disease development remain largely unknown. Knowing the causative genes is not only important in understanding the disease process but also provides a range of benefits in the diagnosis, development of tailored treatments, and identification of new targets for therapy. Studying families with multiple cases of these diseases is a powerful approach used to identify the causative genes. Funded by: Cancer Council of Tasmania - Grant-Cancer Research ($20,000); University of Tasmania.
  • GRANT
    Combining deep sequencing and linkage approaches to identify rare variants contributing to familial prostate cancers
    1 Nov 2013 - 31 Dec 2014
    People funded by this grant:
    • Dickinson J,
    • Thomson R,
    • Charlesworth J,
    • Holloway A,
    • Jarman S
    Project Total: $35,000; Funded by: Cancer Council of Tasmania - Grant-Cancer Research ($35,000); University of Tasmania.
  • GRANT
    Genetic aetiology of familial haematological malignancies
    1 Nov 2013 - 31 Dec 2014
    People funded by this grant:
    • Dickinson J,
    • Charlesworth J,
    • Thomson R,
    • Lowenthal R
    Project Total: $35,000; The project outlines the genetic analysis of a rare resource, utilising high density SNP genotyping to perform familial linkage analysis of twelve large families. It will identify genes predisposing to haematological malignancies in a novel dataset. Funded by: Cancer Council of Tasmania - Grant-Cancer Research ($35,000); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Combining neuroimaging and genomics to elucidate the mechanisms surrounding neurodegeneration
    Texas Biomedical Research Institute30 Apr 2013 - 31 Dec 2015
    People funded by this grant:
    • Charlesworth JC
    Project Total: $101,665; This project involves the analysis of the "Genetics of Brain Structure" (GOBS) and Australian MS genomics data specifically focused on phenotypes relevant to neurodegeneration, lesion formation and multiple sclerosis. Funded by: Texas Biomedical Research Institute ($101,665)
  • GRANT
    Finding glaucoma susceptibility variants by sequencing large families known to carry disease genes
    1 Jan 2013 - 31 Dec 2016
    People funded by this grant:
    • Charlesworth J,
    • Blangero J,
    • Mackey D,
    • Burdon K
    Project Total: $671,329; Primary open angle glaucoma is a chronic eye disease and one of the leading causes of visual impairment and blindness worldwide. This study will use cutting-edge genetic methods to look at the entire coding component of the human genome (exome) in 271 individuals from large glaucoma families. Our previous studies have shown that these families carry genetic variants that increase disease risk. This investigation aims to identify these genes, with the hope they may offer novel targets for treatment or diagnosis. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project ($1,342,658); University of Tasmania.
  • GRANT
    To search for genetic causes of renal disease in the Tiwi Island Aboriginal population
    1 Jul 2012 - 31 Dec 2015
    People funded by this grant:
    • Thomson R,
    • Hoy W,
    • McMorran B,
    • Jose M,
    • Hilder E
    Project Total: $613,169; Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project ($1,226,338); University of Tasmania.
  • GRANT
    Identifying inherited factors underlying familial haematological malignancies
    1 Jan 2012 - 30 Jun 2013
    People funded by this grant:
    • Dickinson J,
    • Stankovich J,
    • Charlesworth J,
    • Lowenthal R,
    • Marsden K
    Project Total: $49,362; Funded by: David Collins Leukaemia Foundation - Grant ($49,362); University of Tasmania.
  • GRANT
    Epigenomics of familial prostate cancer
    1 Jul 2011 - 31 Mar 2013
    People funded by this grant:
    • Charlesworth J,
    • Holloway A,
    • Dickinson J
    Project Total: $14,000; Funded by: Cancer Council of Tasmania - Grant-Small ($14,000); University of Tasmania.
  • GRANT
    Identification of susceptibility genes for familial haematological malignancies
    1 Jan 2011 - 31 Mar 2012
    People funded by this grant:
    • Dickinson J,
    • Foote S,
    • Stankovich J,
    • Lowenthal R,
    • Thomson R
    Project Total: $91,224; Funded by: Leukaemia Foundation - Grant-In-Aid ($91,224); University of Tasmania.